查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1887018

心臟病学正子断层扫描 (PET) 市场规模、占有率、成长及全球产业分析：依类型、应用和地区划分的洞察，以及 2024 年至 2032 年的预测

Cardiology Positron Emission Tomography Scan Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 120 Pages | 商品交期: 请询问到货日

价格

心臟病学正子断层扫描 (PET) 市场成长驱动因素

随着全球对先进的非侵入性心臟诊断工具的需求不断增长，全球心臟病学正子断层扫描 (PET) 市场持续扩张。根据最近的一份报告，受心臟病患病率上升、成像系统技术进步以及精准诊断日益普及的推动，全球心臟病学正电子发射断层扫描 (PET) 市场规模预计在 2024 年将达到 19.1 亿美元。受人口老化和临床对早期、精准心臟评估日益增长的需求驱动，预计该市场将稳步增长，到 2025 年达到 19.7 亿美元。展望未来，预计到 2032 年，该市场将成长至 25.6 亿美元，2025 年至 2032 年的复合年增长率 (CAGR) 为 3.8%。

2024 年，北美以 55.49% 的市场占有率引领全球市场，这得益于其强大的医疗保健基础设施、混合 PET/CT 系统的快速普及以及心臟成像领域持续不断的产品审批。

市场驱动因素

透过技术创新提高诊断准确性

先进的 PET/CT 和 PET/MRI 扫描仪的日益普及是推动心臟 PET 影像变革的关键因素。领先企业正大力投资人工智慧驱动的影像系统，这些系统可提供更高的精确度、更快的扫描速度，并改善心肌灌注、冠状动脉血流储备和发炎的可视化效果。这些创新有助于提升临床决策水平，并支持个人化治疗策略。

2024年6月，西门子医疗推出Biograph Trinion PET/CT扫描仪，标誌着其发展历程中的重要里程碑。该扫描仪采用人工智慧驱动的工作流程和整合式患者监护功能。此外，2024年9月，GE医疗的下一代PET MPI追踪剂Flyrcado（Flupiridaz F 18）获得FDA批准，用于诊断冠状动脉疾病（CAD）。这些进展凸显了下一代心臟影像系统在全球日益普及的现象。

市场限制因子

设备成本高且缺乏熟练专业人员

儘管PET/CT系统在诊断方面非常重要，但其价格昂贵，介于22.5万美元至75万美元之间，这使得中小型医疗机构难以实施，从而限制了市场。

此外，核医专业人员的短缺，包括核医技师、放射性药物专家和心臟影像医师，也是一项重大挑战。缺乏培训机会和严格的监管要求减缓了其普及速度，尤其是在新兴市场。

市场机会

对先进影像和工作流程最佳化的需求不断增长

全球心血管疾病（CVD）负担日益加重，推动了对早期诊断和改善治疗方案的需求。这为提供速度更快、解析度更高、工作流程更有效率的成像系统的製造商创造了巨大的机会。

技术开发商与诊断服务提供者之间的合作正在加速市场扩张。例如，IONETIX 与 Provision Diagnostic Imaging 于 2024 年 2 月签署的合作协议旨在提高放射性示踪剂的供应量并加快诊断结果的出具。

市场挑战

放射性示踪剂供应短缺

放射性示踪剂短缺仍然是全球市场的一大瓶颈。许多示踪剂的半衰期很短，需要附近的加速器设施。 2024 年 10 月，英国国家医疗服务体系 (NHS) 报告放射性同位素严重短缺，导致全国心臟影像手术的延误。这些供应链波动阻碍了稳定运营，并限制了高价值 PET 系统的充分利用。

依细分市场概览

依付款方式

2024年，由于审批流程更快、医疗服务提供者选择更多以及个人化治疗方案，私人医疗保险/自费市场将引领市场成长。

在CMS等监理机关提出的报销改革方案的支持下，公共医疗保险市场预计将实现温和成长。

依服务提供者

2024年，由于拥有先进的影像基础设施和熟练的医护人员，医院占了最大的市场占有率。

由于等待时间缩短、成本优势以及PET/CT系统采购方面合作增多，诊断中心预计将以最高的复合年增长率增长。

区域洞察

北美

北美在2024年以10.6亿美元的市场规模领跑，这主要得益于冠状动脉疾病（CAD）的高发病率以及对精准诊断的大力投资。美国仍然是最大的贡献者，这得益于医院和影像网路持续的产品应用和PET/CT设备的升级。

欧洲

欧洲在2024年维持了显着的市场占有率，这主要得益于医疗保健的数位化程度不断提高以及主要PET设备製造商的存在。对诊断技术现代化的投资将继续推动该地区的成长。

亚太地区

预计亚太地区在预测期内将实现最高的复合年增长率，这主要得益于医疗保健投资的增加、先进影像技术的普及以及放射性药物研发领域合作的拓展。

拉丁美洲和中东及非洲

由于心血管疾病 (CVD) 发病率上升、医疗保健支出增加以及技术逐步普及，因此两个地区预计将保持稳定增长。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：主要发现

  • 近期产业发展动态，包括合作、併购
  • 部分国家心臟病盛行率（2024 年）
  • 新产品发布
  • 主要产业趋势与主要参与者

第五章 全球心臟病学正子断层扫描 (PET) 市场分析、洞察与预测 (2019-2032)

  • 市场分析、洞察与预测 - 依支付方式划分
    • 公共支付
    • 私人医疗保险/自费
  • 市场分析、洞察与预测 - 依服务提供者划分
    • 医院
    • 诊断中心
    • 其他
  • 市场分析、洞察与预测 - 依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美正子断层扫描心臟病学正子断层扫描 (PET) 市场分析、洞察与预测 (2019-2032)

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲心臟病学正子断层扫描 (PET) 市场分析、洞察与预测 (2019-2032)

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 欧洲其他地区

第八章：亚太地区心臟病学正子断层扫描 (PET) 市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章：拉丁美洲心臟病学正子断层扫描 (PET) 市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第十章：中东与非洲心臟病学正子断层扫描 (PET) 市场分析、洞察与预测（2019-2032）

  • 依国家/地区
    • 海湾合作委员会 (GCC)
    • 南非
    • 中东和非洲其他地区

第十一章 竞争分析

  • 全球市占率分析 (2024)
  • 公司简介
    • RadNet, Inc.
    • Sonic Healthcare Limited
    • Akumin Inc.
    • Apex Radiology
    • Alliance Medical Limited
    • Novant Health
    • InHealth Group
    • Dignity Health
    • Concord Medical
    • Siemens Healthcare Limited
    • Mediworks
    • 其他主要参与者
Product Code: FBI113310

Growth Factors of cardiology positron emission tomography (PET) scan Market

The global cardiology positron emission tomography (PET) scan market continues to expand as demand for advanced non-invasive cardiac diagnostic tools increases worldwide. According to the latest report, the global cardiology PET scan market size was valued at USD 1.91 billion in 2024, supported by rising cardiac disease prevalence, technological advancements in imaging systems, and greater adoption of precision diagnostics. The market is expected to reach USD 1.97 billion in 2025, reflecting steady growth driven by the rising geriatric population and increasing clinical preference for early and accurate cardiac evaluations. Looking ahead, the market is forecast to grow to USD 2.56 billion by 2032, exhibiting a CAGR of 3.8% from 2025 to 2032.

In 2024, North America dominated the global market with a 55.49% share, fueled by strong healthcare infrastructure, rapid adoption of hybrid PET/CT systems, and continual product approvals in the cardiac imaging domain.

Market Drivers

Technological Advancements Amplify Diagnostic Precision

The increasing introduction of advanced PET/CT and PET/MRI scanners is a key driver transforming cardiology PET imaging. Major players are heavily investing in AI-enabled imaging systems that offer superior accuracy, faster scan times, and enhanced visualization of myocardial perfusion, coronary flow reserve, and inflammation. These innovations strengthen clinical decision-making and support personalized treatment strategies.

A significant milestone was achieved in June 2024, when Siemens Healthineers launched its PET/CT scanner Biograph Trinion, featuring AI-driven workflows and integrated patient monitoring. Additionally, in September 2024, GE HealthCare received FDA approval for Flyrcado (flurpiridaz F 18), a next-generation PET MPI tracer for diagnosing Coronary Artery Disease (CAD). These advancements highlight the growing adoption of next-level cardiac imaging systems globally.

Market Restraints

High Equipment Costs and Shortage of Skilled Professionals

Despite its diagnostic significance, the market faces limitations due to the high cost of PET/CT systems, which ranges between USD 225,000 and USD 750,000, making these systems difficult to adopt in small and mid-sized healthcare settings.

Furthermore, the shortage of nuclear medicine professionals-including nuclear technologists, radiopharmaceutical specialists, and cardiac imaging physicians-remains a major challenge. Insufficient training opportunities and stringent regulatory requirements slow down widespread adoption, particularly in emerging markets.

Market Opportunities

Growing Demand for Advanced Imaging and Workflow Optimization

The rising global burden of cardiovascular diseases (CVDs) has heightened the demand for early diagnosis and improved treatment planning. This creates strong opportunities for manufacturers offering faster, high-resolution, and workflow-efficient imaging systems.

Partnerships between technology developers and diagnostic providers are accelerating market expansion. For example, IONETIX's partnership with Provision Diagnostic Imaging in February 2024 aims to improve radiotracer availability and reduce diagnostic turnaround times.

Market Challenges

Limited Radiotracer Availability

Radiotracer shortages remain a critical bottleneck for the global market, as many tracers require nearby cyclotron facilities due to their short half-life. In October 2024, the U.K.'s NHS reported severe radioisotope shortages that led to nationwide delays in cardiac imaging procedures. These supply chain fluctuations hinder consistent operations and limit the full utilization of high-value PET equipment.

Segmental Overview

By Source of Payment

The private health insurance/out-of-pocket segment dominated the market in 2024 due to faster approvals, wider provider choice, and personalized treatment packages.

The public segment is expected to witness moderate growth, supported by revised reimbursement proposals from regulatory agencies such as CMS.

By Service Provider

In 2024, hospitals held the largest market share, supported by advanced imaging infrastructure and availability of skilled staff.

Diagnostic centers are projected to grow at the fastest CAGR due to shorter waiting times, cost advantages, and increasing partnerships for PET/CT system procurement.

Regional Insights

North America

North America led the market with USD 1.06 billion in 2024, driven by high CAD prevalence and strong investments in precision diagnostics. The U.S. remains the largest contributor, supported by continual product installations and PET/CT upgrades across hospitals and imaging networks.

Europe

Europe held a substantial market share in 2024, supported by healthcare digitalization initiatives and the presence of leading PET device manufacturers. Investments in diagnostic modernization continue to strengthen regional growth.

Asia Pacific

Asia Pacific is projected to record the highest CAGR during the forecast period due to rising healthcare investments, improved access to advanced imaging, and growing collaborations for radiopharmaceutical development.

Latin America & Middle East/Africa

Both regions are witnessing steady growth driven by increasing CVD incidence, rising healthcare spending, and gradual technology adoption.

Conclusion

With the market expanding from USD 1.91 billion in 2024 to USD 2.56 billion by 2032, the global cardiology PET scan market is poised for consistent growth. Advancements in imaging technologies, expanding diagnostic infrastructure, and rising cardiac disease prevalence will continue to shape the industry's future.

Segmentation By Source of Payment

  • Public
  • Private Health Insurance/Out-of-pocket

By Service Provider

  • Hospitals
  • Diagnostic Centers
  • Others

By Geography

  • North America (By Source of Payment, Service Provider, and Country)
    • U.S.
    • Canada
  • Europe (By Source of Payment, Service Provider, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Source of Payment, Service Provider, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Source of Payment, Service Provider, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Source of Payment, Service Provider, and Country/Sub-region)
    • GCC
    • South Africa
    • Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Recent Industry Developments such as Partnerships, Mergers, and Acquisitions
  • 4.2. Prevalence of Cardiac Conditions, Key Countries, 2024
  • 4.3. New Product Launches
  • 4.4. Key Industry Developments, Key Players

5. Global Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Source of Payment
    • 5.1.1. Public
    • 5.1.2. Private Health Insurance/Out-of-pocket
  • 5.2. Market Analysis, Insights and Forecast - By Service Providers
    • 5.2.1. Hospitals
    • 5.2.2. Diagnostic Centers
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa

6. North America Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Source of Payment
    • 6.1.1. Public
    • 6.1.2. Private Health Insurance/Out-of-pocket
  • 6.2. Market Analysis, Insights and Forecast - By Service Providers
    • 6.2.1. Hospitals
    • 6.2.2. Diagnostic Centers
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
    • 6.3.2. Canada

7. Europe Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Source of Payment
    • 7.1.1. Public
    • 7.1.2. Private Health Insurance/Out-of-pocket
  • 7.2. Market Analysis, Insights and Forecast - By Service Providers
    • 7.2.1. Hospitals
    • 7.2.2. Diagnostic Centers
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.3.1. U.K.
    • 7.3.2. Germany
    • 7.3.3. France
    • 7.3.4. Spain
    • 7.3.5. Italy
    • 7.3.6. Scandinavia
    • 7.3.7. Rest of Europe

8. Asia pacific Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Source of Payment
    • 8.1.1. Public
    • 8.1.2. Private Health Insurance/Out-of-pocket
  • 8.2. Market Analysis, Insights and Forecast - By Service Providers
    • 8.2.1. Hospitals
    • 8.2.2. Diagnostic Centers
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.3.1. Japan
    • 8.3.2. China
    • 8.3.3. India
    • 8.3.4. Australia
    • 8.3.5. Southeast Asia
    • 8.3.6. Rest of Asia Pacific

9. Latin America Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Source of Payment
    • 9.1.1. Public
    • 9.1.2. Private Health Insurance/Out-of-pocket
  • 9.2. Market Analysis, Insights and Forecast - By Service Providers
    • 9.2.1. Hospitals
    • 9.2.2. Diagnostic Centers
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.3.1. Brazil
    • 9.3.2. Mexico
    • 9.3.3. Rest of Latin America

10. Middle East & Africa Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Source of Payment
    • 10.1.1. Public
    • 10.1.2. Private Health Insurance/Out-of-pocket
  • 10.2. Market Analysis, Insights and Forecast - By Service Providers
    • 10.2.1. Hospitals
    • 10.2.2. Diagnostic Centers
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.3.1. GCC
    • 10.3.2. South Africa
    • 10.3.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles
    • 11.2.1. RadNet, Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Sonic Healthcare Limited
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Akumin Inc.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Apex Radiology
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Alliance Medical Limited
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Novant Health
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. InHealth Group
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Dignity Health
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Concord Medical
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Siemens Healthcare Limited
      • 11.2.10.1. Overview
      • 11.2.10.2. Products
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)
    • 11.2.11. Mediworks
      • 11.2.11.1. Overview
      • 11.2.11.2. Products
      • 11.2.11.3. SWOT Analysis
      • 11.2.11.4. Recent Developments
      • 11.2.11.5. Strategies
      • 11.2.11.6. Financials (Based on Availability)
    • 11.2.12. Other Prominent Players
      • 11.2.12.1. Overview
      • 11.2.12.2. Products
      • 11.2.12.3. SWOT Analysis
      • 11.2.12.4. Recent Developments
      • 11.2.12.5. Strategies
      • 11.2.12.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2019-2032
  • Table 2: Global Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2019-2032
  • Table 3: Global Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Region, 2019-2032
  • Table 4: North America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2019-2032
  • Table 5: North America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2019-2032
  • Table 6: North America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country, 2019-2032
  • Table 7: Europe Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2019-2032
  • Table 8: Europe Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2019-2032
  • Table 9: Europe Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 10: Asia Pacific Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2019-2032
  • Table 11: Asia Pacific Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2019-2032
  • Table 12: Asia Pacific Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 13: Latin America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2019-2032
  • Table 14: Latin America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2019-2032
  • Table 15: Latin America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 16: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2019-2032
  • Table 17: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2019-2032
  • Table 18: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

List of Figures

  • Figure 1: Global Cardiology Positron Emission Tomography Scan Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
  • Figure 2: Global Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2024 & 2032
  • Figure 3: Global Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2024 & 2032
  • Figure 4: Global Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Region, 2024 & 2032
  • Figure 5: North America Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Source of Payment, 2024 & 2032
  • Figure 6: North America Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2024
  • Figure 7: North America Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Service Providers, 2024 & 2032
  • Figure 8: North America Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2024
  • Figure 9: North America Cardiology Positron Emission Tomography Scan Market Value (USD billion), By Country, 2024 & 2032
  • Figure 10: North America Cardiology Positron Emission Tomography Scan Market Value Share (%), By Country, 2024
  • Figure 11: Europe Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Source of Payment, 2024 & 2032
  • Figure 12: Europe Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2024
  • Figure 13: Europe Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Service Providers, 2024 & 2032
  • Figure 14: Europe Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2024
  • Figure 15: Europe Cardiology Positron Emission Tomography Scan Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 16: Europe Cardiology Positron Emission Tomography Scan Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 17: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Source of Payment, 2024 & 2032
  • Figure 18: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2024
  • Figure 19: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Service Providers, 2024 & 2032
  • Figure 20: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2024
  • Figure 21: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 22: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 23: Latin America Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Source of Payment, 2024 & 2032
  • Figure 24: Latin America Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2024
  • Figure 25: Latin America Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Service Providers, 2024 & 2032
  • Figure 26: Latin America Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2024
  • Figure 27: Latin America Cardiology Positron Emission Tomography Scan Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 28: Latin America Cardiology Positron Emission Tomography Scan Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 29: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Source of Payment, 2024 & 2032
  • Figure 30: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2024
  • Figure 31: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Service Providers, 2024 & 2032
  • Figure 32: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2024
  • Figure 33: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 34: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 35: Global Cardiology Positron Emission Tomography Scan Market Share (%), By Company, 2024